3-36996633-C-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000231790.8(MLH1):c.131C>A(p.Ser44Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S44F) has been classified as Pathogenic.
Frequency
Genomes: not found (cov: 32)
Consequence
MLH1
ENST00000231790.8 missense
ENST00000231790.8 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 4.74
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 15 uncertain in ENST00000231790.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-36996633-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 17079.Status of the report is reviewed_by_expert_panel, 3 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.979
PP5
Variant 3-36996633-C-A is Pathogenic according to our data. Variant chr3-36996633-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 619504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996633-C-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLH1 | NM_000249.4 | c.131C>A | p.Ser44Tyr | missense_variant | 2/19 | ENST00000231790.8 | NP_000240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH1 | ENST00000231790.8 | c.131C>A | p.Ser44Tyr | missense_variant | 2/19 | 1 | NM_000249.4 | ENSP00000231790 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Colorectal cancer, hereditary nonpolyposis, type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Palindrome, Gene Kavoshgaran Aria | Sep 16, 2024 | - - |
Lynch syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | University of Washington Department of Laboratory Medicine, University of Washington | May 01, 2018 | MLH1 NM_000249.3:c.131C>A has a 99.6% probability of pathogenicity based on combining prior probability from public data with a likelihood ratio of 26.5 to 1, generated from evidence of seeing this as a somatic mutation in a tumor with loss of heterozygosity at the MLH1 locus. See Shirts et al 2018, PMID 29887214. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2019 | The p.S44Y variant (also known as c.131C>A), located in coding exon 2 of the MLH1 gene, results from a C to A substitution at nucleotide position 131. The serine at codon 44 is replaced by tyrosine, an amino acid with dissimilar properties. In one study, protein functional analysis was performed in assays using a hybrid human-yeast MLH1 gene and p.S44Y demonstrated significantly reduced mismatch repair activity (Ellison AR et al. Nucleic Acids Res., 2004 Oct;32:5321-38). Another alteration at the same codon, p.S44F, has been reported as pathogenic based on identification in individuals meeting clinical criteria for HNPCC/Lynch syndrome, segregation with disease, and deficient mismatch repair activity in functional studies (Bronner CE, Nature 1994 Mar; 368(6468):258-61; Tannergård P, Cancer Res. 1995 Dec; 55(24):6092-6; Salahshor S et al. Lab. Invest., 2001 Apr;81:535-41; de Jong AE et al. Clin. Cancer Res., 2004 Feb;10:972-80; Lagerstedt Robinson K et al. J. Natl. Cancer Inst., 2007 Feb;99:291-9; Takahashi M, Cancer Res. 2007 May; 67(10):4595-604; Drost M et al. Hum. Mutat., 2010 Mar;31:247-53). Based on an internal structural assessment, p.S44Y leads to general local structural disruption of a structurally sensitive region (Guarné A et al. EMBO J., 2001 Oct;20:5521-31). This variant was identified as somatic in conjunction with loss of heterozygosity of MLH1 in Lynch syndrome-related tumors demonstrating MMR deficiency by IHC (Shirts BH et al. Am. J. Hum. Genet. 2018 07;103:19-29; Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved through mammals, but not in all available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of ubiquitination at K43 (P = 0.1287);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at